2022
The use of intraovarian injection of autologous platelet rich plasma (PRP) in patients with poor ovarian response and premature ovarian insufficiency
Herlihy NS, Seli E. The use of intraovarian injection of autologous platelet rich plasma (PRP) in patients with poor ovarian response and premature ovarian insufficiency. Current Opinion In Obstetrics & Gynecology 2022, 34: 133-137. PMID: 35645011, DOI: 10.1097/gco.0000000000000784.Peer-Reviewed Original ResearchConceptsPoor ovarian responsePlatelet-rich plasmaPrimary ovarian insufficiencyPoor prognosis patientsPrognosis patientsOvarian reserveIntraovarian injectionOvarian responseOvarian insufficiencyLive birthsRich plasmaEffect of PRPAutologous platelet-rich plasmaIntra-ovarian injectionPremature ovarian insufficiencyMultiple live birthsProspective trialCase seriesClinical trialsPatient's abilityNovel treatmentsPatientsEmbryo yieldInsufficiencyTreatment
2021
B-cell lymphoma 6 expression is not associated with live birth in a normal responder in vitro fertilization population
Klimczak AM, Herlihy NS, Scott CS, Hanson BM, Kim JG, Titus S, Seli E, Scott RT. B-cell lymphoma 6 expression is not associated with live birth in a normal responder in vitro fertilization population. Fertility And Sterility 2021, 117: 351-358. PMID: 34809978, DOI: 10.1016/j.fertnstert.2021.09.036.Peer-Reviewed Original ResearchConceptsB-cell lymphoma 6 (Bcl6) expressionLive birth groupLive birthsFertilization populationNormal respondersBirth groupProportion of patientsLive birth ratePopulation of patientsEuploid embryo transferCase-control studyEndometrial tissue samplesPreimplantation genetic testingGroup of womenIVF stimulationMean HSCOREIVF outcomesInfertility centerIVF successMAIN OUTCOMEGroup 2Group 1Embryo transferPatientsClinical decisionEmerging follicular activation strategies to treat women with poor ovarian response and primary ovarian insufficiency
Reig A, Herraiz S, Pellicer A, Seli E. Emerging follicular activation strategies to treat women with poor ovarian response and primary ovarian insufficiency. Current Opinion In Obstetrics & Gynecology 2021, 33: 241-248. PMID: 33896920, DOI: 10.1097/gco.0000000000000703.Peer-Reviewed Original ResearchConceptsPoor ovarian responsePrimary ovarian insufficiencyLive birthsOngoing pregnancyOvarian responseOvarian insufficiencyAutologous platelet-rich plasmaBone marrow transplantFemale reproductive agingPlatelet-rich plasmaIntraovarian injectionOvarian transplantationMarrow transplantReproductive agingFertility treatmentReproductive medicineWomenPregnancyBirthInsufficiencyPrevious reportsPreliminary studyMechanical disruptionAkt stimulationCutting-edge strategies
2013
Current trends and progress in clinical applications of oocyte cryopreservation
Cil AP, Seli E. Current trends and progress in clinical applications of oocyte cryopreservation. Current Opinion In Obstetrics & Gynecology 2013, 25: 247-254. PMID: 23562954, PMCID: PMC3869229, DOI: 10.1097/gco.0b013e32836091f4.Peer-Reviewed Original ResearchConceptsElective oocyte cryopreservationOocyte cryopreservationSuccess rateClinical applicationFresh donor oocytesFresh oocytesClinical success rateFirst live birthIVF success ratesCommon indicationElective useDonor oocytesAppropriate counselingLive birthsClinical successMedical indicationsCryopreserved oocytesOocyte vitrificationAvailable evidenceReproductive medicinePostponement of fertilityAmerican SocietyIVFOocytesIndications
2011
Preterm deliveries that result from multiple pregnancies associated with assisted reproductive technologies in the USA: a cost analysis
Bromer JG, Ata B, Seli M, Lockwood CJ, Seli E. Preterm deliveries that result from multiple pregnancies associated with assisted reproductive technologies in the USA: a cost analysis. Current Opinion In Obstetrics & Gynecology 2011, 23: 168-173. PMID: 21372712, DOI: 10.1097/gco.0b013e32834551cd.Peer-Reviewed Original ResearchConceptsMultiple pregnanciesPreterm deliveryPreterm infantsNumber of embryosInfant deliveryAssisted reproductive technology cyclesElective single embryo transferART live birthsReproductive technology cyclesSingle embryo transferFinancial burdenART neonatesART twinsMedical complicationsART cyclesLive birthsSubstantial burdenMean costPregnancyEmbryo transferART tripletsInfantsHealthcare expendituresHealth science policyReproductive technologies